Generics Partner Tells Justices It Can Appeal PTAB Ruling
Argentum Pharmaceuticals has told the U.S. Supreme Court that it should be allowed to appeal its failed attempt to challenge a Novartis multiple sclerosis drug patent, even though its development partner is...To view the full article, register now.
Already a subscriber? Click here to view full article